MPM BioVentures 2014, L.P. 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-12-09 8:23 pm Sale | 2021-12-06 | 13D | iTeos Therapeutics, Inc. ITOS | MPM BioVentures 2014, L.P. | 4,730,197 13.400% | -407,017 (-7.92%) | Filing |
| 2021-10-19 4:06 pm Sale | 2021-10-13 | 13D | iTeos Therapeutics, Inc. ITOS | MPM BioVentures 2014, L.P. | 5,137,214 14.600% | -438,998 (-7.87%) | Filing |
| 2021-09-21 4:32 pm Sale | 2021-09-16 | 13D | iTeos Therapeutics, Inc. ITOS | MPM BioVentures 2014, L.P. | 5,576,212 13.000% | -486,008 (-8.02%) | Filing |
| 2020-08-07 5:42 pm Purchase | 2020-07-28 | 13D | iTeos Therapeutics, Inc. ITOS | MPM BioVentures 2014, L.P. | 6,062,220 18.100% | 6,062,220 (New Position) | Filing |